Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Amortization of Goodwill (2022)

LivaNova recorded quarterly Amortization of Goodwill of $4000.0 in Q4 2022, down 100.0% quarter-over-quarter from $129.4 million in Q3 2022.

LivaNova's Amortization of Goodwill history runs 1 years deep, the most recent figure standing at $4000.0 for Q4 2022.

  • In Q4 2022, Amortization of Goodwill changed N/A year-over-year to $4000.0; the TTM figure through Dec 2023 stood at $129.4 million (changed 0.0% YoY), while the FY2022 annual figure was $129.4 million, changed N/A from the prior year.
  • Amortization of Goodwill came in at $4000.0 for Q4 2022 at LivaNova, down from $129.4 million in the prior quarter.
  • In the past five years, Amortization of Goodwill ranged from a high of $129.4 million in Q3 2022 to a low of $4000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 LivaNova 4.03 Bn 3.45 Bn 243.75 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 4,000.00
Dec 31, 2022 4,000.00
Sep 30, 2022 129.40 Mn
Sep 30, 2022 129.40 Mn